← FDA DRUG APPROVALS

FDA ANDA · ANDA072320

PANCURONIUM BROMIDE

Sponsor: HOSPIRA

APPLICATION
ANDA072320
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-19
LATEST ACTION
2018-07-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PANCURONIUM BROMIDEDiscontinued
PANCURONIUM BROMIDE 1MG/ML · INJECTABLE · INJECTION

Approval history

2018-07-26Labeling · Supplement 28 · standardAP
2010-11-22Labeling · Supplement 20AP
2009-04-15Labeling · Supplement 18AP
2004-09-07Labeling · Supplement 13AP
1999-07-08Manufacturing (CMC) · Supplement 12AP
1999-03-12Manufacturing (CMC) · Supplement 10AP
1999-03-12Manufacturing (CMC) · Supplement 8AP
1998-10-08Manufacturing (CMC) · Supplement 11AP
1998-04-08Manufacturing (CMC) · Supplement 9AP
1996-10-22Manufacturing (CMC) · Supplement 7AP
1995-08-11Manufacturing (CMC) · Supplement 3AP
1995-08-11Labeling · Supplement 4AP
1995-08-11Manufacturing (CMC) · Supplement 2AP
1994-05-27Manufacturing (CMC) · Supplement 6AP
1989-12-15Labeling · Supplement 1AP
1989-01-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →